Oncology Department
Marc Peeters has not added Biography.
If you are Marc Peeters and would like to personalize this page please email our Author Liaison for assistance.
Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial.
Acta gastro-enterologica Belgica Oct-Dec, 2006 | Pubmed ID: 17343077
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2007 | Pubmed ID: 17470858
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
Annals of surgical oncology Feb, 2008 | Pubmed ID: 17960463
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2008 | Pubmed ID: 18316791
Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Acta gastro-enterologica Belgica Oct-Dec, 2007 | Pubmed ID: 18330088
Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
European journal of cancer (Oxford, England : 1990) Oct, 2008 | Pubmed ID: 18707864
Unusual serum electrophoresis pattern in a woman with pancreatic carcinoma.
Clinical chemistry Sep, 2008 | Pubmed ID: 18755907
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2008 | Pubmed ID: 18794099
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Cancer investigation Oct, 2008 | Pubmed ID: 18853313
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?
The oncologist Jan, 2009 | Pubmed ID: 19144681
Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study.
Cancer chemotherapy and pharmacology Sep, 2009 | Pubmed ID: 19184020
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.
Cancer Apr, 2009 | Pubmed ID: 19189371
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2009 | Pubmed ID: 19318496
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
BMC cancer , 2009 | Pubmed ID: 19366444
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.
Oncology reports Jul, 2009 | Pubmed ID: 19513511
Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.
Histology and histopathology Aug, 2009 | Pubmed ID: 19554504
Forcing cancer cells to commit suicide.
Cancer biotherapy & radiopharmaceuticals Aug, 2009 | Pubmed ID: 19694574
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2009 | Pubmed ID: 19738126
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.
Cancer biotherapy & radiopharmaceuticals Oct, 2009 | Pubmed ID: 19877886
Cardiovascular risk status can influence the colorectal cancer screening strategy.
Digestion , 2010 | Pubmed ID: 20029205
Psychometric evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness.
The oncologist , 2010 | Pubmed ID: 20189976
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
BMC cancer , 2010 | Pubmed ID: 20459770
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2010 | Pubmed ID: 20567019
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma.
Cancer Nov, 2010 | Pubmed ID: 20669326
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2010 | Pubmed ID: 20837948
Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
Future oncology (London, England) Sep, 2010 | Pubmed ID: 20919831
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2010 | Pubmed ID: 20921462
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
Nuclear medicine and biology Nov, 2010 | Pubmed ID: 21055628
The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing.
Cancer epidemiology Feb, 2011 | Pubmed ID: 21095173
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
Virchows Archiv : an international journal of pathology Feb, 2011 | Pubmed ID: 21113617
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent.
Radiation research Jan, 2011 | Pubmed ID: 21175342
Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab.
International journal of colorectal disease Feb, 2011 | Pubmed ID: 21190026
EGFR in melanoma: clinical significance and potential therapeutic target.
Journal of cutaneous pathology Jun, 2011 | Pubmed ID: 21352258
Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells.
International journal of radiation oncology, biology, physics Jun, 2011 | Pubmed ID: 21377279
In vivo imaging of apoptosis in oncology: an update.
Molecular imaging Oct, 2011 | Pubmed ID: 21521554
Digestive oncologist in the gastroenterology training curriculum.
World journal of gastroenterology Mar, 2011 | Pubmed ID: 21556128
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Magma (New York, N.Y.) Aug, 2011 | Pubmed ID: 21567161
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society Dec, 2011 | Pubmed ID: 21618031
Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.
Cancer treatment reviews Aug, 2012 | Pubmed ID: 21899955
Panitumumab in combination with cytotoxic chemotherapy for the treatment of metastatic colorectal carcinoma.
Clinical colorectal cancer Mar, 2012 | Pubmed ID: 21925954
(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov, 2011 | Pubmed ID: 22045708
Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material.
Diagnostic molecular pathology : the American journal of surgical pathology, part B Dec, 2011 | Pubmed ID: 22089347
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
Lancet (London, England) Dec, 2011 | Pubmed ID: 22119496
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.
Clinical & developmental immunology , 2011 | Pubmed ID: 22162712
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Annals of surgical oncology Jul, 2012 | Pubmed ID: 22395983
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.
Molecular imaging Apr, 2012 | Pubmed ID: 22469241
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
BMC cancer , 2012 | Pubmed ID: 22494623
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
Annals of surgical oncology Sep, 2012 | Pubmed ID: 22526897
Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) Jan, 2013 | Pubmed ID: 22706167
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2012 | Pubmed ID: 22753904
Will the medical student in the team please stand up?
The Lancet. Oncology Aug, 2012 | Pubmed ID: 22846828
The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
Current pharmaceutical design , 2013 | Pubmed ID: 22973959
Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays.
PloS one , 2012 | Pubmed ID: 23094027
Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.
BMC cancer , 2012 | Pubmed ID: 23148666
Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb, 2013 | Pubmed ID: 23182985
Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2013 | Pubmed ID: 23325582
Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples.
Diagnostic molecular pathology : the American journal of surgical pathology, part B Mar, 2013 | Pubmed ID: 23370428
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
BMC cancer , 2013 | Pubmed ID: 23587148
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer.
Targeted oncology Jun, 2013 | Pubmed ID: 23625191
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.
The oncologist , 2013 | Pubmed ID: 23821327
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting.
Expert opinion on therapeutic targets Aug, 2013 | Pubmed ID: 23848525
Antineoplastic therapy-induced pulmonary toxicity.
Expert review of anticancer therapy Aug, 2013 | Pubmed ID: 23984900
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?
Expert opinion on biological therapy Jun, 2014 | Pubmed ID: 24673103
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.
The Lancet. Oncology May, 2014 | Pubmed ID: 24739896
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response.
BMC research notes , 2014 | Pubmed ID: 24899223
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.
Cancer treatment reviews Sep, 2014 | Pubmed ID: 24953979
The role of targeted therapy for gastrointestinal tumors.
Expert review of gastroenterology & hepatology Nov, 2014 | Pubmed ID: 24957206
ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply.
The Lancet. Oncology Jul, 2014 | Pubmed ID: 24988928
Use of antiemetics in the prevention of chemotherapy-induced nausea and vomiting: review and focus on the Belgian situation.
Acta gastro-enterologica Belgica Jun, 2014 | Pubmed ID: 25090823
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.
BMC cancer , 2014 | Pubmed ID: 25128202
Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins.
Cancer letters Nov, 2014 | Pubmed ID: 25192874
Liquid biopsies in lung cancer: the new ambrosia of researchers.
Biochimica et biophysica acta Dec, 2014 | Pubmed ID: 25444714
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.
Cancer letters Jan, 2015 | Pubmed ID: 25449778
FOLFIRI with cetuximab or bevacizumab: FIRE-3.
The Lancet. Oncology Dec, 2014 | Pubmed ID: 25456374
Case histories in unresectable liver-dominant metastatic colorectal cancer.
Future oncology (London, England) Nov, 2014 | Pubmed ID: 25478766
Cancer and the microbiome: potential applications as new tumor biomarker.
Expert review of anticancer therapy Mar, 2015 | Pubmed ID: 25495037
Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer.
Oncoscience , 2014 | Pubmed ID: 25593984
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.
Journal of molecular endocrinology Apr, 2015 | Pubmed ID: 25612765
Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer.
Current treatment options in oncology Apr, 2015 | Pubmed ID: 25813037
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Cancer immunology, immunotherapy : CII Jul, 2015 | Pubmed ID: 25863943
Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
BMC cancer , 2015 | Pubmed ID: 25879441
Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status.
Drugs May, 2015 | Pubmed ID: 25895463
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer.
European journal of cancer (Oxford, England : 1990) Jul, 2015 | Pubmed ID: 25956209
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
The New England journal of medicine May, 2015 | Pubmed ID: 25970050
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.
BMC research notes , 2015 | Pubmed ID: 26032726
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
European journal of cancer (Oxford, England : 1990) Sep, 2015 | Pubmed ID: 26049686
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward.
Gastroenterology research and practice , 2015 | Pubmed ID: 26101524
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer.
Oncotarget Sep, 2015 | Pubmed ID: 26125230
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
American journal of cancer research , 2015 | Pubmed ID: 26269754
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?
Oncotarget Sep, 2015 | Pubmed ID: 26318427
Study protocol for a randomized controlled trial: tongue strengthening exercises in head and neck cancer patients, does exercise load matter?
Trials , 2015 | Pubmed ID: 26340887
Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages.
Cancer genetics Oct, 2015 | Pubmed ID: 26341699
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2015 | Pubmed ID: 26341920
Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2.
Drugs Oct, 2015 | Pubmed ID: 26347132
A phase I study of volasertib combined with afatinib, in advanced solid tumors.
Cancer chemotherapy and pharmacology Oct, 2015 | Pubmed ID: 26349473
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.
PloS one , 2015 | Pubmed ID: 26421426
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.
Expert opinion on investigational drugs , 2015 | Pubmed ID: 26457764
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
The oncologist Jan, 2016 | Pubmed ID: 26712958
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.
Minerva chirurgica Jan, 2016 | Pubmed ID: 26771252
Reducing Compounds Equivocally Influence Oxidation during Digestion of a High-Fat Beef Product, which Promotes Cytotoxicity in Colorectal Carcinoma Cell Lines.
Journal of agricultural and food chemistry Feb, 2016 | Pubmed ID: 26836477
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2016 | Pubmed ID: 26903575
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
Oncotarget Feb, 2016 | Pubmed ID: 26919248
APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.
Cancer letters Jun, 2016 | Pubmed ID: 26975633
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.
British journal of cancer Mar, 2016 | Pubmed ID: 26978006
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment.
Oncotarget Mar, 2016 | Pubmed ID: 26980749
Feasibility of an interactive electronic self-report tool for oral cancer therapy in an outpatient setting.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Mar, 2016 | Pubmed ID: 27025594
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.
International journal of molecular sciences Feb, 2017 | Pubmed ID: 28212293
Validity and Reproducibility of a Food Frequency Questionnaire for Dietary Factors Related to Colorectal Cancer.
Nutrients Nov, 2017 | Pubmed ID: 29149033
The predictive value of primary tumor location in patients with metastatic colorectal cancer: A systematic review.
Critical reviews in oncology/hematology Jan, 2018 | Pubmed ID: 29279095
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients.
Clinical colorectal cancer Jun, 2018 | Pubmed ID: 29605591
Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies.
Clinical colorectal cancer Sep, 2018 | Pubmed ID: 29627309
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.
Cancers Apr, 2018 | Pubmed ID: 29690507
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.
British journal of cancer Aug, 2018 | Pubmed ID: 30013091
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib.
Cancers Jan, 2019 | Pubmed ID: 30650638
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.
Cancers Mar, 2019 | Pubmed ID: 30935089
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
International journal of molecular sciences May, 2019 | Pubmed ID: 31052546
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
Cancers Oct, 2019 | Pubmed ID: 31635070
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform.
ESMO open Jun, 2020 | Pubmed ID: 32571785
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
ESMO open Oct, 2021 | Pubmed ID: 34597941
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.
Pharmacology & therapeutics Aug, 2022 | Pubmed ID: 34999181
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients.
ESMO open Apr, 2022 | Pubmed ID: 35305399
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
Journal of medical case reports Jul, 2022 | Pubmed ID: 35831829
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review.
Journal of bone oncology Aug, 2022 | Pubmed ID: 35860387
Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy.
Cancers Aug, 2022 | Pubmed ID: 36077610
Prognostic implications of cellular senescence in resected non-small cell lung cancer.
Translational lung cancer research Aug, 2022 | Pubmed ID: 36090630
Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial.
Dysphagia Sep, 2022 | Pubmed ID: 36121560
The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Frontiers in immunology , 2022 | Pubmed ID: 36268020
Point scintillator dosimetry in ultra-high dose rate electron "FLASH" radiation therapy: A first characterization.
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) Nov, 2022 | Pubmed ID: 36302279
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2022 | Pubmed ID: 36341493
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives.
European journal of cancer (Oxford, England : 1990) Jan, 2023 | Pubmed ID: 36427394
Boosting capacity of a fourth dose BNT162b2 in cancer patients.
European journal of cancer (Oxford, England : 1990) Nov, 2022 | Pubmed ID: 36521333
Marco Giallombardo*,1,2,
Jorge Chacártegui Borrás*,2,3,
Marta Castiglia4,
Nele Van Der Steen3,
Inge Mertens5,6,
Patrick Pauwels7,3,
Marc Peeters8,3,
Christian Rolfo2,3
1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo,
2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA),
3Center for Oncological Research (CORE), Antwerp University,
4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo,
5, Flemish Institute for Technological Research (VITO),
6CORE, Campus Groenenborger, Antwerp University,
7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA),
8Oncology Department, Antwerp University Hospital (UZA)
Maxim Le Compte1,
Edgar Cardenas De La Hoz2,
Sofía Peeters1,
Evelien Smits1,
Filip Lardon1,
Geert Roeyen1,3,
Steve Vanlanduit2,
Hans Prenen1,4,
Marc Peeters1,4,
Abraham Lin1,5,
Christophe Deben1
1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp,
2Industrial Vision Lab, University of Antwerp,
3Department of Hepatobiliary Transplantation and Endocrine Surgery, University Hospital Antwerp (UZA),
4Department of Oncology, University Hospital Antwerp (UZA),
5Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유